MRES Stock Overview
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Institute of Biomedical Research Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0083 |
52 Week High | US$0.028 |
52 Week Low | US$0.0069 |
Beta | 0 |
1 Month Change | 10.67% |
3 Month Change | 3.75% |
1 Year Change | -5.14% |
3 Year Change | 418.75% |
5 Year Change | 654.55% |
Change since IPO | -99.86% |
Recent News & Updates
Recent updates
Shareholder Returns
MRES | US Life Sciences | US Market | |
---|---|---|---|
7D | -12.6% | -0.2% | 0.4% |
1Y | -5.1% | 4.5% | 28.8% |
Return vs Industry: MRES underperformed the US Life Sciences industry which returned 3.9% over the past year.
Return vs Market: MRES underperformed the US Market which returned 29.5% over the past year.
Price Volatility
MRES volatility | |
---|---|
MRES Average Weekly Movement | 22.9% |
Life Sciences Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MRES's share price has been volatile over the past 3 months.
Volatility Over Time: MRES's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | n/a | Drasko Pekovic | https://mrescorp.com |
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental scientific research; and development of new diagnostic methods and experimental medical treatments. The company also researchers and develops new biomedical and food products; provides programs for graduate research studies in biomedical and environmental fields; offers two channel analog NMS, digital muscle stimulator, digital TENS, interferential, elite combination, portable four channel digital, portable ultra sound, and other healthcare devices; and provides photon red light for beauty, electric pain relief products, microcurrent electrical nerve stimulators, and high volt pulsed stimulators.
Institute of Biomedical Research Corp. Fundamentals Summary
MRES fundamental statistics | |
---|---|
Market cap | US$19.68m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MRES overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MRES income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did MRES perform over the long term?
See historical performance and comparison